Thrombosis Management in Patients With Atrial Fibrillation and Acute Coronary Syndrome

Gregory Y.H. Lip, MD


October 28, 2020

In elderly patients with atrial fibrillation who develop acute coronary syndrome and may need percutaneous coronary intervention, treatment is complicated because of the risk for thromboembolic bleeding in this population.

In this ReCAP, Dr Gregory Y.H. Lip, director of the Liverpool Centre for Cardiovascular Science in Liverpool, United Kingdom, details the risks and benefits of antithrombotic therapy for this population using oral anticoagulants and antiplatelet drugs. Dr Lip stresses weighing individual risk in deciding whether to use short-term triple therapy in patients with high thrombotic risk or direct oral anticoagulants and P2Y12 inhibitors for patients who have a higher risk of bleeding.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.